Dysport exerts its therapeutic results by inhibiting acetylcholine release at the neuromuscular junction. It selectively targets and binds to presynaptic nerve terminals, avoiding the release of neurotransmitters liable for muscle mass contraction.Clinics that Consider different form A neuromodulators often Examine this preparation with established